HomeInfraredx Inc.

Infraredx Inc.

April 24, 2019: Infraredx Announces FDA Approval of Expanded Label Claim for the Makoto ™ Intravascular Imaging System

“We are very proud of this new milestone that expands the indication for use of the Makoto™ Imaging System and accompanying Dualpro™ IVUS+NIRS catheter to detect both plaques and patients at high risk for dangerous cardiovascular events,” said Nozomu Fujita, President and CEO of Infraredx, a Nipro Company.